IL6 and scleroderma: In summary, we were able to demonstrate that blocking CD47 and IL-6 prevented the loss in fat tissue during disease initiation, reversed fibrotic skin changes thereafter, and eliminated human scleroderma fibroblasts in an adaptive transfer model.